Roundtable Discussion:Navigating & Re-Thinking Market Access Strategies in European Dermatology Drug Development
Time: 1:45 pm
day: Day Two
Details:
In the dynamic landscape of dermatology drug development, securing successful market
access in Europe is a pivotal milestone for biopharma innovators. This interactive discussion brings together large pharma, biotech, clinician and market access strategists to delve into the crucial considerations for planning ahead in this complex journey in a more informed manner compared to today.
Use this opportunity to discuss the intricacies of European regulatory, HTA criteria and payer engagement strategies to optimise development timelines, approval processes, craft reimbursement models and ultimately navigate diverse markets to maximise patient access to novel therapies.
Join us for a collaborative exploration of strategies and insights that will empower
your end-to-end dermatology drug development journey in the European market!
